PLAINSBORO, N.J., Oct. 28, 2002 (PRIMEZONE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART) announced that it has scheduled a conference call for 9:00 a.m. EST on Monday, November 4 to discuss financial results for the third quarter ended September 30, 2002 and to update forward-looking financial guidance. Financial results for the third quarter 2002 will be announced via a news release issued before the market opens on November 4.
The upcoming conference call, which will be hosted by Stuart Essig, President and Chief Executive Officer of Integra, is open to all listeners and will be followed by a question and answer session. Additional forward-looking information may be discussed in the question and answer session following the call.
Access to the live call is available by dialing (973) 582-2729 or through a listen-only webcast via a link provided on the home page of Integra's website at www.Integra-LS.com. A replay of the conference call will be accessible starting one hour following the live event. Access to the replay is available through November 18, 2002 by dialing 973-341-3080 (PIN code 3462254) or through the webcast accessible on our home page.
Integra also announced today that it is scheduled to present at the CIBC World Markets 13th Annual Healthcare Conference at The Plaza Hotel in New York City on Monday, November 4 at 4:00 p.m. ET. The presentation will be delivered by Stuart Essig, President and Chief Executive Officer of Integra. Access to the live presentation is available to the general public through a webcast that can be accessed through the Calendar Events link in the Investor Relations section of Integra's website at www.Integra-LS.com. Additionally, a replay of this webcast presentation will be available through November 18, 2002.
Mr. Essig's presentation will provide an overview of the Company's operating divisions, a review of recent financial history, including financial results from the third quarter ended September 30, 2002, and the Company's overall business strategy.
Integra LifeSciences Holdings Corporation develops, manufactures and markets medical devices, implants and biomaterials primarily used in the treatment of cranial and spinal disorders, soft tissue repair and orthopedics. Integra is a leader in applying the principles of biotechnology to medical devices that improve patients' quality of life. Integra has its corporate headquarters in Plainsboro, New Jersey, with manufacturing and research facilities located throughout the world. Integra has approximately 750 permanent employees.
Statements made in the upcoming conference call may be forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from predicted results. Forward-looking factors that may be discussed include, but are not limited to, expected future financial results, new product development, governmental approvals, market potential, expected sales and potential therapeutic applications of new products, and additional business acquisitions. In addition, the economic, competitive, governmental, technological and other factors identified under the heading "Risk Factors" included in the Business section of Integra's Annual Report on Form 10-K for the year ended December 31, 2001 and information contained in subsequent filings with the Securities and Exchange Commission could affect actual results.